Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)

from Thinking Thoracic · host thinkingthoracic

Jessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.

Episode metadata supplied by the publisher feed · Published Feb 18, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)

0:00 1:11:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Thinking Thoracic?

This episode is 1 hour and 11 minutes long.

When was this Thinking Thoracic episode published?

This episode was published on February 18, 2026.

Can I download this Thinking Thoracic episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!